Combination etanercept and methotrexate provides better disease control in very early (4 months and

ConclusionsTreatment of VERA with ETN+MTX provides qualitatively improved clinical outcomes not seen with MTX monotherapy, supporting the pivotal role of TNF inhibition in early disease. (Source: Annals of the Rheumatic Diseases)
Read More... [Source: MedWorm: Allergy & Immunology - Posted by FreeAutoBlogger]